Langerhans Cell Histiocytosis With Mutation Successfully Treated With Trametinib.
The discovery of the MAPK pathway mutations in lesions of patients with Langerhans cell histiocytosis (LCH) has made targeted therapy an important therapeutic approach for these patients...